Acerus Pharmaceuticals Corporation (ASP.TO)
Company Info
| ISIN | CA00444G4051 |
|---|---|
| CUSIP | 00444G405 |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
Highlights
| Market Cap | CA$2.77M |
|---|---|
| EPS | -CA$4.41 |
| Revenue (TTM) | CA$3.04M |
| Gross Profit (TTM) | CA$1.00M |
| EBITDA (TTM) | -CA$25.32M |
| Year Range | CA$0.28 - CA$1.29 |
| Target Price | CA$0.38 |
| Short % | 0.03% |
| Short Ratio | 0.14 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of CA$10,000 in Acerus Pharmaceuticals Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Return
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | N/A | 19.92% |
| 1 month | N/A | 5.06% |
| 6 months | N/A | 7.11% |
| 1 year | N/A | 16.17% |
| 5 years (annualized) | N/A | 11.84% |
| 10 years (annualized) | N/A | 9.85% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 0.00% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Acerus Pharmaceuticals Corporation (ASP.TO) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
ASP.TO Acerus Pharmaceuticals Corporation | N/A | ||||
^GSPC S&P 500 | 1.25 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Acerus Pharmaceuticals Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Acerus Pharmaceuticals Corporation was 99.97%, occurring on Jan 10, 2023. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.97% | Apr 16, 2012 | 2694 | Jan 10, 2023 | — | — | — |
| -91.53% | Nov 25, 2009 | 3 | Feb 10, 2010 | 18 | Jan 18, 2011 | 21 |
| -90.22% | Jan 27, 2011 | 3 | Feb 2, 2011 | 3 | Jul 19, 2011 | 6 |
| -48.89% | Jul 20, 2011 | 20 | Aug 18, 2011 | 3 | Aug 23, 2011 | 23 |
| -20% | Oct 3, 2011 | 3 | Oct 5, 2011 | 3 | Oct 11, 2011 | 6 |
Volatility Chart
The current Acerus Pharmaceuticals Corporation volatility is 0.00%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.